Aptamer Group secures contract with major pharma
AIM-listed Aptamer Group developer announces £360,000 deal with top-tier pharmaceutical company alongside strong commercial momentum. Aptamer Group shares jumped on…
0,013€
85,71%
Echtzeit-Aktienkurs Aptamer Group Ltd.
Bid:
Ask:
Nachrichten zur Aptamer Group Ltd. Aktie
Aptamer Group shares jump on revenue growth and strong order book
Aptamer Group plc, the AIM-listed developer of Optimer® binders for life sciences innovation, has revealed a significant upturn in sales…